Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor

James N. Kochenderfer, Mark E. Dudley, Sadik H. Kassim, Robert P.T. Somerville, Robert O. Carpenter, Stetler Stevenson Maryalice, James C. Yang, Giao Q. Phan, Marybeth S. Hughes, Richard M. Sherry, Mark Raffeld, Steven Feldman, Lily Lu, Yong F. Li, Lien T. Ngo, Andre Goy, Tatyana Feldman, David E. Spaner, Michael L. Wang, Clara C. ChenSarah M. Kranick, Avindra Nath, Debbie Ann N. Nathan, Kathleen E. Morton, Mary Ann Toomey, Steven A. Rosenberg

Research output: Contribution to journal › Article › peer-review

1316 Scopus citations

Fingerprint

Dive into the research topics of 'Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor'. Together they form a unique fingerprint.

Medicine & Life Sciences